Article Information
History
- October 29, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Jewell N. Walters†,1,
- Blake Schouest†,1,
- Ami Patel†,2,
- Emma L. Reuschel†,2,
- Katherine Schultheis1,
- Elizabeth Parzych2,
- Igor Maricic1,
- Ebony N. Gary2,
- Mansi Purwar2,
- Viviane M. Andrade1,
- Arthur Doan1,
- Dustin Elwood1,
- Zeena Eblimit1,
- Brian Nguyen1,
- Drew Frase2,
- Faraz I. Zaidi2,
- Abhijeet Kulkarni2,
- Alison Generotti1,
- J Joseph Kim1,
- Laurent M. Humeau1,
- Stephanie J. Ramos1,
- Trevor R.F. Smith1,
- David B. Weiner2,* and
- Kate E. Broderick1,*
- 1Inovio Pharmaceuticals, Plymouth Meeting, PA, 19462, USA
- 2Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, PA, 19104, USA
- ↵*Corresponding authors; email: kate.broderick{at}inovio.com
↵† Authors contributed equally